Trainee Exposure and Education for Minimally Invasive Gender-Affirming Procedures

Brittany Buhalog; Jon Klint Peebles; Matthew Mansh; Esther A. Kim; Philip Daniel Knott; William Hoffman; Rahul Seth; Andre Alcon; Sarah Tuttleton Arron

doi:10.1016/j.det.2019.10.009

Trainee Exposure and Education for Minimally Invasive Gender-Affirming Procedures

Brittany Buhalog, Jon Klint Peebles, Matthew Mansh, Esther A. Kim, Philip Daniel Knott, William Hoffman, Rahul Seth, Andre Alcon, Sarah Tuttleton Arron

Dermatology

Research output: Contribution to journal › Review article › peer-review

Abstract

Minimally invasive gender-affirming procedures (MIGAPs), which aim to align gender identity and expression for transgender and gender-nonbinary patients in a way that is safe, effective, and semipermanent or reversible, are gaining in popularity. This article assesses the current amount of trainee exposure in clinic and didactic sessions in core procedural specialties nationwide via survey study of program directors. Low exposure of residents and fellows to MIGAPs was observed overall and a lack of procedure-specific education. In an effort to provide excellent patient care, promote cultural humility, and improve patients’ quality of life, further education regarding these procedures is necessary.

Original language	English (US)
Pages (from-to)	277-283
Number of pages	7
Journal	Dermatologic Clinics
Volume	38
Issue number	2
DOIs	https://doi.org/10.1016/j.det.2019.10.009
State	Published - Apr 2020

Bibliographical note

Funding Information:
S.T. Arron reports the following conflicts of interest: investigator for Leo Pharma, SunPharma, Menlo Therapeutics, Castle Biosciences, Genentech/Roche, Pfizer, Regeneron, Eli Lilly, PellePharm; consultant for Enspectra Health, Regeneron, Sanofi-Genzyme, Castle Creek Pharmaceuticals, SunPharma, Pennside Partners, Biossance, Gerson Lehrman Group, Rakuten Aspyrian. The remaining authors have nothing to disclose.

Publisher Copyright:
© 2019 Elsevier Inc.

Keywords

Cultural humility
Gender-affirming procedures
Medical education
Minimally invasive procedures
Nonbinary
Transgender

PubMed: MeSH publication types

Journal Article

Access

10.1016/j.det.2019.10.009

Cite this

Trainee Exposure and Education for Minimally Invasive Gender-Affirming Procedures. / Buhalog, Brittany; Peebles, Jon Klint; Mansh, Matthew; Kim, Esther A.; Knott, Philip Daniel; Hoffman, William; Seth, Rahul; Alcon, Andre; Arron, Sarah Tuttleton.

In: Dermatologic Clinics, Vol. 38, No. 2, 04.2020, p. 277-283.

Research output: Contribution to journal › Review article › peer-review

@article{c8350e87f6824fb28b75b063f4e907fd,

title = "Trainee Exposure and Education for Minimally Invasive Gender-Affirming Procedures",

abstract = "Minimally invasive gender-affirming procedures (MIGAPs), which aim to align gender identity and expression for transgender and gender-nonbinary patients in a way that is safe, effective, and semipermanent or reversible, are gaining in popularity. This article assesses the current amount of trainee exposure in clinic and didactic sessions in core procedural specialties nationwide via survey study of program directors. Low exposure of residents and fellows to MIGAPs was observed overall and a lack of procedure-specific education. In an effort to provide excellent patient care, promote cultural humility, and improve patients{\textquoteright} quality of life, further education regarding these procedures is necessary.",

keywords = "Cultural humility, Gender-affirming procedures, Medical education, Minimally invasive procedures, Nonbinary, Transgender",

author = "Brittany Buhalog and Peebles, {Jon Klint} and Matthew Mansh and Kim, {Esther A.} and Knott, {Philip Daniel} and William Hoffman and Rahul Seth and Andre Alcon and Arron, {Sarah Tuttleton}",

note = "Funding Information: S.T. Arron reports the following conflicts of interest: investigator for Leo Pharma, SunPharma, Menlo Therapeutics, Castle Biosciences, Genentech/Roche, Pfizer, Regeneron, Eli Lilly, PellePharm; consultant for Enspectra Health, Regeneron, Sanofi-Genzyme, Castle Creek Pharmaceuticals, SunPharma, Pennside Partners, Biossance, Gerson Lehrman Group, Rakuten Aspyrian. The remaining authors have nothing to disclose. Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = apr,

doi = "10.1016/j.det.2019.10.009",

language = "English (US)",

volume = "38",

pages = "277--283",

journal = "Dermatologic Clinics",

issn = "0733-8635",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Trainee Exposure and Education for Minimally Invasive Gender-Affirming Procedures

AU - Buhalog, Brittany

AU - Peebles, Jon Klint

AU - Mansh, Matthew

AU - Kim, Esther A.

AU - Knott, Philip Daniel

AU - Hoffman, William

AU - Seth, Rahul

AU - Alcon, Andre

AU - Arron, Sarah Tuttleton

N1 - Funding Information: S.T. Arron reports the following conflicts of interest: investigator for Leo Pharma, SunPharma, Menlo Therapeutics, Castle Biosciences, Genentech/Roche, Pfizer, Regeneron, Eli Lilly, PellePharm; consultant for Enspectra Health, Regeneron, Sanofi-Genzyme, Castle Creek Pharmaceuticals, SunPharma, Pennside Partners, Biossance, Gerson Lehrman Group, Rakuten Aspyrian. The remaining authors have nothing to disclose. Publisher Copyright: © 2019 Elsevier Inc.

PY - 2020/4

Y1 - 2020/4

N2 - Minimally invasive gender-affirming procedures (MIGAPs), which aim to align gender identity and expression for transgender and gender-nonbinary patients in a way that is safe, effective, and semipermanent or reversible, are gaining in popularity. This article assesses the current amount of trainee exposure in clinic and didactic sessions in core procedural specialties nationwide via survey study of program directors. Low exposure of residents and fellows to MIGAPs was observed overall and a lack of procedure-specific education. In an effort to provide excellent patient care, promote cultural humility, and improve patients’ quality of life, further education regarding these procedures is necessary.

AB - Minimally invasive gender-affirming procedures (MIGAPs), which aim to align gender identity and expression for transgender and gender-nonbinary patients in a way that is safe, effective, and semipermanent or reversible, are gaining in popularity. This article assesses the current amount of trainee exposure in clinic and didactic sessions in core procedural specialties nationwide via survey study of program directors. Low exposure of residents and fellows to MIGAPs was observed overall and a lack of procedure-specific education. In an effort to provide excellent patient care, promote cultural humility, and improve patients’ quality of life, further education regarding these procedures is necessary.

KW - Cultural humility

KW - Gender-affirming procedures

KW - Medical education

KW - Minimally invasive procedures

KW - Nonbinary

KW - Transgender

UR - http://www.scopus.com/inward/record.url?scp=85076253356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076253356&partnerID=8YFLogxK

U2 - 10.1016/j.det.2019.10.009

DO - 10.1016/j.det.2019.10.009

M3 - Review article

C2 - 32115138

AN - SCOPUS:85076253356

VL - 38

SP - 277

EP - 283

JO - Dermatologic Clinics

JF - Dermatologic Clinics

SN - 0733-8635

IS - 2

ER -

Trainee Exposure and Education for Minimally Invasive Gender-Affirming Procedures

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

Access

Other files and links

Fingerprint

Cite this